Skip to content
Press Release
FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community  New York City, NY (September 11, 2025) – The...

4 Minute Read
Press Release |
November 30, 2015

Sheila – #GivingTuesday 2015

#GivingTuesday is TOMORROW! Join Sheila in Supporting the MRF.   #GivingTuesday is in less than 24 hours! Your tax-deductible gift received on #GivingTuesday will help...

2 Minute Read
Blogs |
November 30, 2015

Graham – #GivingTuesday 2015

#GivingTuesday is TOMORROW, December 1! Join Graham in Supporting the MRF.   During the holiday season, we are especially grateful for the children in our lives and th...

2 Minute Read
Blogs |
November 25, 2015

Julie & Amelia – #GivingTuesday 2015

#GivingTuesday is Tuesday, December 1, 2015! Join Julie and Amelia in Supporting the MRF.   #GivingTuesday is Tuesday, December 1 and your gift to the Melanoma Researc...

2 Minute Read
Press Release |
November 12, 2015

Guest Post: Dr. Sacks, Ocular Melanoma and Gratitu...

Ocular melanoma survivor Anne Marie Montijo reflects on the passing of Dr. Oliver Sacks and her own goal to live each day with a spirit of gratitude.

3 Minute Read
Blogs |
November 10, 2015

FDA Approves New Targeted Therapy Combination (Vem...

Today, the FDA approved the targeted therapy combination of vemurafenib (Zelboraf®) with cobimetinib (Cotellic) for people who have advanced or metastatic melanoma and who...

4 Minute Read
Blogs |
November 6, 2015

Washington, D.C. Community Combats Melanoma at 7th...

Washington, D.C. – On Saturday, November 7th, the Washington, D.C. melanoma community will come together to honor those who have been impacted by melanoma and raise f...

4 Minute Read
Press Release |
October 30, 2015

#CUREOM Unite! – Thank You!

The results are in and #CUREOM Unite! was a tremendous success! Thank you to everyone who gave so generously to this campaign to further patient-centered ocular melanoma (O...

2 Minute Read
Blogs |
October 27, 2015

FDA Approves First New Adjuvant Treatment for Stag...

Statement from Tim Turnham, Executive Director, Melanoma Research Foundation   Washington, D.C.—Today the Food and Drug Administration (FDA) approved ipilimumab ...

3 Minute Read
Press Release |
October 27, 2015

FDA Approves Talimogene Laherparepvec (T-VEC) for ...

Today the FDA approved Amgen’s drug, Imlygic (Talimogene Laherparepvec or T-VEC), for the treatment of unresectable Stage IIIB, IIIC or IV metastatic melanoma, bringing a...

3 Minute Read
Blogs |
October 14, 2015

Guest Post: Dr. Richard Carvajal – #CUREOM U...

For the last decade, Dr. Richard Carvajal has dedicated his career to the research and treatment of rare cancers like ocular melanoma (OM) and understands the need for more...

2 Minute Read
Press Release |
October 6, 2015

Guest Post: Connie’s Story

Guest blogger Connie Popp shares her experience as an ocular melanoma caregiver, advocate and participant in Miles for Melanoma in support of the CURE OM Unite! campaign. 3 Minute Read

Blogs |
September 30, 2015

FDA Approves Opdivo and Yervoy Combination for Adv...

  Statement from Tim Turnham, Executive Director, Melanoma Research Foundation   The Melanoma Research Foundation (MRF) applauds the FDA’s approval of the c...

3 Minute Read

Oct 16, 2025 ET

Ask the Expert: Mucosal Melanoma – Current and Emerging Treatments, Research and Patient Perspectives

Oct 16, 2025 ET

5th Annual #GetNakedJax

Oct 18, 2025 ET

San Diego Miles for Melanoma 5K

Oct 25, 2025 ET

CURE OM Global Science Meeting

Oct 30, 2025 ET

Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

Oct 30, 2025 ET

24th Annual New York Gala

Nov 02, 2025 ET

Atlanta Miles for Melanoma 5K

Explore Events